ORCID as entered in ROS

Select Publications
2024, 'Exploiting the dna damage response to develop personalised treatments for high-risk sarcoma in children', Lorne, presented at Lorne Cancer, Lorne, 09 February 2024, https://cancer-2024.p.asnevents.com.au/days/2024-02-09/abstract/100289
,2024, 'Phosphoproteomic profiling for novel target identification in childhood sarcomas: Paving the road towards improved outcomes for relapsed and metastatic osteosarcoma', Lorne, presented at 36th Lorne Cancer Conference 2024, Lorne, 09 February 2024, https://cancer-2024.p.asnevents.com.au/days/2024-02-09/abstract/100264
,